Evidence map›Paper›PMID 39250503›Full record

ArticlePLoS pathogens2024

NLRP1-dependent activation of Gasdermin D in neutrophils controls cutaneous leishmaniasis.

Michiel Goris, Katiuska Passelli, Sanam Peyvandi, Miriam Díaz-Varela, Oaklyne Billion, Borja Prat-Luri, Benjamin Demarco, Chantal Desponds, Manon Termote, Eva Iniguez and 6 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Neutrophil death-more than meets the eye.Experimental hematology · 2025
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Michiel GorisDepartment of Immunobiology, University of Lausanne, Epalinges, Switzerland.
Katiuska PasselliDepartment of Immunobiology, University of Lausanne, Epalinges, Switzerland.
Sanam PeyvandiDepartment of Immunobiology, University of Lausanne, Epalinges, Switzerland.
Miriam Díaz-VarelaDepartment of Immunobiology, University of Lausanne, Epalinges, Switzerland.
Oaklyne BillionDepartment of Immunobiology, University of Lausanne, Epalinges, Switzerland.
Borja Prat-LuriDepartment of Immunobiology, University of Lausanne, Epalinges, Switzerland.
Benjamin DemarcoDepartment of Immunobiology, University of Lausanne, Epalinges, Switzerland.
Chantal DespondsDepartment of Immunobiology, University of Lausanne, Epalinges, Switzerland.
Manon TermoteDepartment of Immunobiology, University of Lausanne, Epalinges, Switzerland.
Eva IniguezVector Molecular Biology Section, Laboratory of Malaria and Vector Research, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Somaditya DeyVector Molecular Biology Section, Laboratory of Malaria and Vector Research, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Bernard MalissenINSERM, CNRS, Centre D'Immunologie de Marseille-Luminy, Aix-Marseille Université, Marseille, France.
Shaden KamhawiVector Molecular Biology Section, Laboratory of Malaria and Vector Research, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Benjamin P HurrellDepartment of Immunobiology, University of Lausanne, Epalinges, Switzerland.
Petr BrozDepartment of Immunobiology, University of Lausanne, Epalinges, Switzerland.
Fabienne Tacchini-CottierDepartment of Immunobiology, University of Lausanne, Epalinges, Switzerland.ORCID 0000-0003-3561-0207

Funding

Indian Council of Medical Research, Government of India INDO/FRC/452/Y-32/2022-23-IHNIH HHS SNSF) 310030_184751 AND 310030_184751/2
6 · The paper itself

Abstract

Intracellular pathogens that replicate in host myeloid cells have devised ways to inhibit the cell's killing machinery. Pyroptosis is one of the host strategies used to reduce the pathogen replicating niche and thereby control its expansion. The intracellular Leishmania parasites can survive and use neutrophils as a silent entry niche, favoring subsequent parasite dissemination into the host. Here, we show that Leishmania mexicana induces NLRP1- and caspase-1-dependent Gasdermin D (GSDMD)-mediated pyroptosis in neutrophils, a process critical to control the parasite-induced pathology. In the absence of GSDMD, we observe an increased number of infected dermal neutrophils two days post-infection. Using adoptive neutrophil transfer in neutropenic mice, we show that pyroptosis contributes to the regulation of the neutrophil niche early after infection. The critical role of neutrophil pyroptosis and its positive influence on the regulation of the disease outcome was further demonstrated following infection of mice with neutrophil-specific deletion of GSDMD. Thus, our study establishes neutrophil pyroptosis as a critical regulator of leishmaniasis pathology.

Indexed as

Intracellular Signaling Peptides and ProteinsLeishmaniasis, CutaneousNeutrophilsPhosphate-Binding ProteinsPyroptosisAdaptor Proteins, Signal TransducingAnimalsApoptosis Regulatory ProteinsGasderminsLeishmania mexicanaMiceMice, Inbred C57BLMice, KnockoutAdaptor Proteins, Signal TransducingApoptosis Regulatory ProteinsGasderminsGsdmd protein, mouseIntracellular Signaling Peptides and ProteinsPhosphate-Binding Proteins

Identifiers

PMID39250503
PMCPMC11412672

What Socratic holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.